![Ronald Dubner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald Dubner
Corporate Officer/Principal at Xalud Therapeutics, Inc.
Ronald Dubner active positions
Companies | Position | Start | End |
---|---|---|---|
Xalud Therapeutics, Inc.
![]() Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
Career history of Ronald Dubner
Statistics
International
United States | 2 |
Operational
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Xalud Therapeutics, Inc.
![]() Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Ronald Dubner
- Experience